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INTRODUCTION

Prostaglandins (PG) are a family of twenty carbon hydroxylated
fatty acids with a cyclopentane ring bearing oxygens on carbons 9
and 11.

Prostaglandins were discovered independently by von Euler

(1934) in Sweden and Goldblatt (1933) in England.

Between 1957 and

1963 Bergstrom and his colleagues in Sweden isolated several prosta
glandins from the sheep seminal vesicles and elucidated their chem
ical structures.

Since then, steady progress has been made on the

biochemistry and pharmacology of prostaglandins.
Since the present study deals with the action of prostaglandins
on gastric and intestinal secretion, it is pertinent to briefly
review the literature concerned with these activities.
Several natural prostaglandins of the A and E types were first
found to inhibit gastric secretion in dogs stimulated with histamine,
food, pentagastrin and 2-deoxy-d-glucose by Robert and coworkers
(Robert e t a l ., 1967; Robert, 1968; Nezamis e t a l . , 1971).

Volume,

acid output, acid concentration, and pepsin output were reduced in
a dose dependent maimer, whereas pepsin concentration did not change
significantly.

These findings have been confirmed in dogs (Wilson

and Levine, 1969; Jacobson, 1970) and extended to other animal
species (Shaw and Ramwell, 1968; Robert e t a l . , 1968; Whittle,
1972) including humans (Classen e t a l . , 1970 and 1971; Wilson,

e t a l . , 1971).

1

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

PGEX, perfused directly into the gastric lumen of rats, inhibited
gastric secretion induced with pentagastrin (Banerjee e t a l . 3 1972;
Shaw and Ramwell, 1968; Shaw and Urquhart, 1973; Whittle, 1972)
histamine (Shaw and Ramwell, 1968; Shaw and Urquhart, 1972; Whittle,
1972) and vagal stimulation (Shaw and Ramwell, 1968; Shaw and
Urquhart, 1972).

PGE2 given intravenously or perfused through

the stomach inhibited gastric secretion stimulated by cyclic adeno
sine monophosphate (cyclic AMP) (Whittle, 1972).

In the pylorus-

ligated rat, PGE2 given orally at high doses also inhibited gastric
secretion (acid concentration and output but not volume or pepsin
output) (Lee e t a l . t 1973; Robert e t a t ., 1976).

PGE2 inhibited

gastric secretion (volume acid concentration and output, pepsin out
put) when given subcutaneously (Robert e t a l ., 1976).
Several prostaglandins, administered either into the superior
mesenteric artery (PGAX, PGEX, PGF2a in dogs) (Greenough e t a l . 3
1969; Pierce e t al. 3 1971), intravenously (PGF2a in humans);
(Cummings e t a l . 3 1973) or directly into the lumen of the small
intestine [PGEi in humans (Matuchansky and Bernier, 1971, 1973) and
dogs (Pierce e t a l ., 1971)], were found to evoke the accumulation of
fluid (water and electrolytes) into the lumen.

In humans, the

accumulation of fluid after PGEX was not accompanied by a change
in intestinal transit time (Matuchansky e t a l . 3 1972).

Intrajejunal

administration of PGE2 to healthy volunteers produced net excretion
of water, sodium, potassium and chloride.

Within two hours after

perfusion of 325 yg of PGE2, all subjects experienced one to three

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

episodes of watery diarrhea (Hinsdale e t al. 3 1974).

Using the dis

tal rabbit ileum incubated in v i t r o 3 PGEi and PGF2a, added to the
serosal side, inhibited the absorption of sodium from the mucosal
side (Al Awqati and Greenough, 1972).

Similarly, PGE2 inhibited

sodium and chloride absorption (fluxes from mucosa to serosa) in rat
jejunum in v i t r o (Declusin e t oil., 1974).

Thus, it appears that the

net intestinal secretion of fluid produced by prostaglandins is the
stun of the fluid transported into the lumen and the portion of the
intestinal water and electrolytes whose absorption through the
intestine is inhibited.

Diarrhea observed in animals and humans

receiving large doses of prostaglandins is due for the most part
to the accumulation of fluid in the small intestine.
PGE2 was shown to inhibit gastric secretion several years
ago.

The mechanism of action for its gastric antisecretory activity

is not known.

PGE2 has the opposite effect on the intestine-stimu-

lation of secretion.

This study explored the possibility that the

accumulation of fluid in the intestine is in part responsible for
the reduction of fluid in the stomach.
To investigate this hypothesis, I tested PGE2 for gastric
antisecretory activity in a gutless rat and induced intestinal
secretion with hypertonic solutions while monitoring the gastric
secretion in the pylorus ligated rat.
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MATERIALS AND METHODS

Gastric Secretion Studies

Pylorus Ligated Intact Rat
Female Upjohn rats (derived from the Sprague-Dawley strain)
weighing 185-200 gm were used in all experiments.
fasted for 24 hours prior to experimentation.

The rats were

Additionally,water

was withheld during 16-17 hours of the fasting period.

The rats

were placed in cylindrical stainless steel restraining cages to pre
vent them from eating their hair and feces.
On the morning of the experiments, body fluids lost during
fasting were replaced with 10 ml saline, administered subcutaneously.
It was observed that rats drank very little when deprived of food
and lost 10-15 gms during fasting.

Rats receiving hypertonic fluid

intraduodenally or isotonic fluid intravenously did not receive
(10 ml) saline subcutaneously.
One hour after the saline administration, the pylorus was
ligated under ether anesthesia as described by Shay e t a l .

(1945).

Four or five hours after pylorus ligation, the animals were killed
with carbon dioxide, then the stomachs were removed and the accumu
lated gastric juice was collected in a graduated test tube.
Pylorus Ligated Gutless Rat
The animals were treated the same as the pylorus ligated intact
rat except that along with pylorus ligation the intestine was re
moved.

Four ligatures were needed.

A ligature was placed around

4
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the rectum and its vessels.

The portal vein with coeliac and super

ior mesenteric vessels were ligated.

Next, the bile duct plus the

inferior and superior pancreatic-duodenal vessels were ligated.
The final ligation was the pylorus.
The rectum was cut and the intestinal mass was lifted toward the
stomach.

After the gut was freed by severing its ligamentous and

venous attachments, the duodenum was cut below the pylorus liga
tion.

The pancreas was separated from the duodenum and left in the

abdomen.

The spleen was not removed.

Isotonic Fluid (Sodium Chloride or Mannitol) Injection
Following pylorus ligation of the intact or gutless rat, the
jugular vein was exposed.

Using a 25 gauge needle 5/8 inch long,

the vein was punctured by passing the needle through the pectoralis
muscle.

Seven milliliters of fluid was injected within one minute.

The skin was closed using one wound clip.

After 11 / 2 hours, the

animal was re-anesthetized and an additional 7 ml was injected
in the same or the other jugular vein.

Control animals underwent

the same surgical procedures except no fluid was injected.

Rats

receiving intravenous fluid and their controls did not receive sub
cutaneous saline (10 ml) injections.
Hypertonic Fluid (Sodium Chloride or Mannitol) Injection
Immediately after pylorus ligation (under ether anesthesia)
using a 25 gauge, 5/8 inch needle, 1 ml or 2 ml of hypertonic NaCl
or mannitol was injected into the duodenum.

The needle pierced the

duodenum 5 mm from the pylorus, fluid was injected in a downward
direction.
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Intestinal Secretion Studies

At necropsy, the small intestine was cut at the duodenum and at
the ileocecal junction, removed from the abdomen and its contents
were collected into a graduated centrifuge tube by squeezing the
entire length of the small intestine (Robert e t a l. 3 1976).

The

volume was read to the nearest 0.1 ml.

Hematocrit

Immediately before necropsy, a small part of the tail was cut.
Blood was allowed to flow into a capillary tube.

The tube was

plugged with clay and centrifuged in a clinical centrifuge for 4
minutes.

Gastric Juice Analysis

The volume of gastric juice was measured in a graduated centri
fuge tube to the nearest 0.1 ml; acid was titrated with 0.1 N NaOH
to pH 7 with the use of a glass electrode (Copenhagen radio-meter)
and expressed in mEq/L (concentration) and mEq/4 or 5 hr (output).
Pepsin content was determined by the hemoglobin method, as modified
by Vatier e t a l.

(1968), for an autoanalyzer.

Pepsin concentration

was expressed as yEq of tyrosine/ml and pepsin output as yEq tyro
sine/4 or 5 hours.
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Pharmacological Agents

Prostaglandin E2 (Upjohn) was dissolved in 95% ethanol and
administered in 0.5 ml aqueous solution containing 5% ethanolsaline subcutaneously immediately after pylorus ligation at the
following doses;

1, 2.5, 5 and 10 mg/kg.

Vehicle, 5% ethanol-

saline, was given to control animals.
Methscopolamine bromide (Upjohn) was dissolved in 1 ml of
saline, administered subcutaneously at a dose of 1 mg/kg immediately
after pylorus ligation.
Hypertonic sodium chloride was prepared as a 5% (weight-volume)
or 1600 mosmol. in water.

Hypertonic mannitol was prepared as a

30% (weight-volume) or 1600 mosmol. solution in warm water.

In

addition, aqueous isotonic sodium chloride (290 mosmol.) and 5%
(w/v) or 290 mosmol. mannitol solutions were prepared.

Statistical Test

The results are expressed as means for all gastric juice, in
testinal fluid and hematocrit values.

The two-tailed Dunnett T-

test was used; significance was expressed as p<0.05 and p < 0.01.
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RESULTS

Studies on Gastric and Intestinal Secretion of Intact Rats

Gastric Juice
Volume. PGE2 given subcutaneously inhibited gastric juice
volume in a dose dependent manner.

A significant reduction (p <

0.01) was shown at the 2.5 mg/kg dose of PGE2 (Figure 1A). This
level of inhibition was shown 5 hours after treatment but no reduc
tion was apparent at 1 to 3 hours after treatment (Figure 2).
Comparisons were made to control animals receiving vehicle.
Acid. Both acid concentration and output were inhibited by
PGE2 in a dose dependent manner.

A significant inhibition (p <

0.01) was attained with a dose of 2.5 mg/kg (Figure IB and 2).
Pepsin. PGE2 at 10 mg/kg, inhibited pepsin concentration (p <
0.05).

A lower dose, 2.5 mg/kg, inhibited pepsin output (p < 0.01)

at 5 hours after treatment.
Intestinal Fluid Secretion
PGE2 increased intestinal fluid significantly (p < 0.01) within
15 minutes after treatment.

Volume returned to pre-treatment levels

3 hours after treatment (Figure 2).

Studies on Gastric Secretion of Gutless Rats

Gastric Juice
Volume. No significant change in gastric volume was observed
when PGE2 was administered at any of the doses tested.

Unlike the

8

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

intact rat, there was no decrease in volume.

However, a consistent

increase in volume was noted (Figure 3A).
Acid. PGE2 decreased acid concentration, at the 2.5 mg/kg dose
(p < 0.05) but not acid output (Figures 3B and 4).
Pepsin. Pepsin concentration was decreased at the 10 mg/kg
dose (p < 0.05).

Pepsin output, however, was not changed.

Effect of Intravenous Isotonic Fluid on Gastric
and Intestinal Secretion in PGE2-Treated Intact Rats

Gastric Juice
Volume.

Isotonic mannitol (14 ml) given intravenously to PGE2

(5 mg/kg) treated intact rats reversed the PGE2 inhibition of gastric
volume 2 and 3 hours after treatment (Figure5).

PGE2

and intraven

ous fluid produced more volume in the stomach than did the vehicle
treated rats.

This reversal was not observed at 4 or 5 hours after

treatment, but the PGE2 inhibition of gastric volume was blocked.
Isotonic NaCl (14 ml) treatment also blocked PGE2 induced inhi
bition of gastric secretion.
Administration of intravenous fluids had no effect on basal
secretion in the vehicle treated animals.

When PGE2-treated sham

operated group was compared to PGE2 and intravenous isotonic fluid
treated group, there is definite stimulation of gastric volume (p
< 0.05) by isotonic mannitol (Figure 5).
Acid.

Isotonic NaCl and mannitol treatment did not alter the

inhibitory effect of PGE2 on acid concentration (Figure 5), nor did
it block the effect on acid output.
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Pepsin.

PGE2 inhibited pepsin concentration and output (p <

0.01) in intact rats.

Mannitol did not alter pepsin concentration,

but it blocked the inhibitory effect of PGE2 on pepsin output.
Intestinal Fluid Secretion
The PGE2 induced stimulation of intestinal secretion was not
altered by expansion of extracellular fluid volume (Figure 5).

Effect of Intravenous Isotonic NaCl
on Gastric Secretion in PGE2-Treated Gutless Rats

Gastric Juice
Volume. PGE2 (5 mg/kg) increased gastric volume (p < 0.05)
(Figure 6A).

Intravenous saline (14 ml) treatment significantly

(p < 0.01) increased the gastric volume of the gutless rat receiv
ing PGE2, 4 hours after treatment (Figure 6A).
Acid. Acid concentration was reduced by PGE2 (p < 0.01), but
acid output was not changed from controls.

Intravenous saline did

not influence the PGE2-induced inhibition of acid concentration
(Figure 6B).

PGE2 did not inhibit acid output in the gutless rat.

Intravenous saline plus PGE2 did not inhibit acid output.

Effect of Intraduodenal Hypertonic NaCl and
Mannitol on Gastric and Intestinal Secretion

Gastric Juice
Volume. Two milliliters of hypertonic NaCl (5%) significantly
reduced (p < 0.01) gastric volume 3 hours after treatment.
effect was less at 4 hours after treatment.

This

A dose of 1 ml hyper

tonic NaCl showed significant volume reduction at 2 hours (p < 0.05)
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(Figure 7).
Hypertonic mannitol (30%) reduced volume (p < 0.05) 7 hours
after a dose of 1 ml administered intraduodenally (Figure 8).
Acid. It was observed 3 hours after treatment that hypertonic
NaCl (2 ml) reduced acid concentration (p < 0.05).

Acid concentra

tion was the same as in control animals 4 hours after treatment.
Mannitol did not reduce acid concentration during the time
period that acid was determined (6 hours after treatment), but acid
output was significantly reduced (Figure 8).
Pepsin. Hypertonic NaCl (2 ml) had reduced pepsin output (p <
0.05) 4 hours after administration.
changed.

Pepsin concentration was un

Mannitol inhibited pepsin output (p < 0.01) 6 hours after

treatment with a 1 ml dose.
Intestinal Fluid Secretion
Hypertonic NaCl and mannitol increased intestinal fluid within
15 minutes after treatment (Figures 7 and 8).

A level of stimula

tion (p < 0.01) was maintained for 2 hours (sodium chloride) and
7 hours (mannitol).

Intestinal fluid volume stimulated by hyper

tonic solutions was much greater than PGE2 induced intestinal secre
tion; 306% for PGE2, 652% NaCl and 1113% for mannitol (comparisons
were made at 15 minutes after treatment).

Studies on Hematocrit

The hematocrit of control, pylorus-ligated intact and gutless
rats did not change significantly during the experimental time

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

period.

PGE2 did not affect the hematocrit in either preparation

(Figures 2 and 4).
Effect of Intraduodenal Hypertonic Mannitol and NaCl on Hematocrit
Hypertonic mannitol showed a significant increase (p < 0.01)
in hematocrit over control after 15 minutes of treatment whether
1 ml or 2 ml .was injected into the duodenum (Figure 8).

This in

crease was evident 1 hour after 2 ml treatment but lasted only 30
minutes following a 1 ml dose.

Hypertonic NaCl (2 ml) increased

the hematocrit significantly only at 15 minutes after treatment.
Effect of Intravenous Isotonic NaCl and Mannitol on Hematocrit in
PGE2-Treated Rats
The hematocrit of rats receiving isotonic intravenous NaCl or
mannitol and vehicle showed no difference from rats receiving iso
tonic intravenous solution and PGE2 (Figure 5).

Effect of an Anticholinergic Drug on Gastric
and Intestinal Secretion and Hematocrit in
the Intact and Gutless Rats

Methscopolamine bromide (1 mg/kg, subcutaneously) inhibited
(p < 0.01) gastric volume and acid (concentration and output) in
the intact as well as the gutless rat (Figures 9 and 10).

Unlike

PGE2, this antisecretory drug had the same effect on both the intact
and the gutless rat.
Intestinal secretion was not changed by methscopolamine bro
mide nor did the hematocrit show any difference from control rats
(Figure 9).
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FIGURES

In all figures, each column represents mean values.

The same

animals were used for measurement of gastric volume and acid,

intestinal fluid and hematocrit.

The times indicated in Figures

2, 4, 5, 7, 8, and 9 gives the interval between treatment and
necropsy.
A significant comparison between a group and the vehicletreated group is indicated by * = P < 0.05 and ** = P < 0.01.

A

significant comparison between PGE2 plus another treatment or sur
gery compared to PGE2 alone plus sham surgery is indicated by + =
P < 0.05 and ft = P < 0.01.
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Figure I.

Effect of Various Doses of Prostaglandin E2 on Volume (A)
and Acid Concentration (B) of Gastric Juice, 5 Hours After Pylorus
Ligation. Each Column Represents the Mean of 7-11 Rats.
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Effect of PGE2 (2.5 mg/kg) on Gastric Volume and Acid
Concentration, Intestinal Fluid Volume and Hematocrit at Various
Times After Treatment. Each Column Represents the Mean of 3-8 Rats.
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Figure 3.

Effect of Various Boses of PGE2 on Volume (A) and Acid
Concentration (B) of Gastric Juice, 5 Hours After Pylorus Ligation
in Gutless Rats. Each Column Represents the Mean of 4-6 Rats.
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Times After Treatment. Each Column Represents the Mean of 5-6 Rats.
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ml of Isotonic (5%) Mannitol Given Intravenously in Pylorus Ligated
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Figure 6.

Effect of PGE2 (5 mg/kg) on Volume (A) and Acid Concentra
tion (B) of Gastric Juice as Influenced by 14 ml of Isotonic NaCl
(0.9%) Given Intravenously in Pylorus Ligated Gutless Rats, 4 Hours
After Treatment. Each Column represents the Mean of 4-5 Rats.
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Figure 7.

Effect of 1 ml of Hypertonic (5%) NaCI, intraduodenally at
the Time of Pylorus Ligation, On Gastric Volume and Acid Concentra
tion, Intestinal Fluid Volume and Hematocrit at Various Times After
Treatment. Each Column Represents the Mean of 3-4 Rats.
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Figure 8.

Effect of 1 ml of Hypertonic (30%) Mannitol, Intraduodenally at the Time of Pylorus Ligation, On Gastric Volume and Acid
Concentration, Intestinal Fluid Volume and Hematocrit at Various Times
After Treatment. Each Column Represents the Mean of 3—4 Rats.
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Figure 9.

Effect of Subcutaneous Methoscopolamine Bromide on Gastric
Volume and Acid Concentration, Intestinal Fluid Volume and Hematocrit
in Pylorus Ligated Rats at Various Times After Treatment. Each
Column Represents the Mean of 3-4 Rats.
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Figure 10.

Effect of Subcutaneous Methscopolamine Bromide on Gastric
Volume (A) and Acid Concentration (B) in Pylorus Ligated Gutless Bats,
4 Hours After Treatment. Each Column Represents the Mean of 6-10
Rats.
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DISCUSSION

PGE2 inhibited gastric volume, acid and pepsin and increased
intestinal secretion in the pylorus-ligated intact rat (Figures 1
and 2).

However, the gastric volume was not inhibited in the gut

less rat (Figure 3A). PGE2 may reduce gastric volume through in
creased intestinal secretion.

There are other instances when

increased intestinal secretion is associated with reduced gastric
secretion.

Cholera toxin induced intestinal secretion is -abundant

in patients with the disease.

Similarly, gastric acid output is

reduced in cholera patients (Sack e t a t. , 1970).

The inhibition of

basal gastric secretion by intraduodenal hypertonic solutions is
another example of this phenomenon (Figures 7 and 8).
The data obtained from the surgical manipulation of the small
intestine indicated that the absorption of certain substances
secreted by the duodenum is important in maintaining gastric secre
tion of the pylorus-ligated rat (Okabe e t a t. , 1975).

If this is

the case, then abundant intestinal secretion would be expected to
inhibit gastric secretion because net intestinal secretion is the
result of inadequate absorption.
When the gut was removed, PGE2 did not inhibit gastric volume
at any dose tested (Figures 3A and 4).

This is a strong indication

that PGE2 inhibits gastric volume by a mechanism involving the gut.
Intravenous fluids blocked gastric volume inhibition by PGE2 in
the intact pylorus-ligated rat and potentiated gastric volume
24
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increase in the gutless rat, strongly suggesting that blood volume
plays a role (Figures 5 and 6).

If this is true, then the volume of

intestinal secretion in PGE2-treated rats must be such that blood
volume is decreased.

The increase in gastric volume produced by

intravenous isotonic fluid in the PGE2-treated gutless rat may in
dicate that PGE2 stimulates non-parietal cell secretion of the stomach
(Figure 6A).

This is supported by the fact that an analogue of PGE2

(16,16-dimethyl PGE2) stimulated non-acid secretion from the un
stimulated canine gastric mucosa (Bolton e t a t. , 1978) .
Hemoconcentration may not be directly involved in the inhibi
tion of gastric secretion produced by PGE2. Significant hemocon
centration was not shown at doses producing large increases in
intestinal secretion (Figure 2).

Hypertonic NaCI produced abundant

intestinal fluid at a time period which corresponded to the signi
ficant decrease in gastric volume but the hematocrit was not affected
(Figure 7).

An abnormal, increase in intestinal secretion, in itself,

may stimulate gut substances that regulate gastric secretion.

There

fore, it may be concluded that any rapid movement of body fluids
from blood to intestinal lumen will cause a decrease in the volume
of gastric secretion.
PGE2 has direct effects on gastric mucosa function.

In the

isolated canine stomach perfused with blood, the addition of PGE2 to
the blood inhibited acid secretion induced by either histamine,
pentagastria or vagal stimulation (Shaw e t a t. , 1972).
study does not dispute this finding.

The present

I am presenting evidence that
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PGE2 inhibits gastric acid and volume by separate mechanisms.
In the gutless rat, PGE2 promoted fluid secretion by the stomach
similar to its effects on the intestine.

Only the ET1’ concentration

was determined in the gastric juice of this preparation.

Whether

PGE2 affects other ions of gastric juice in a manner similar to its
effects on intestinal ion secretion is not known.
Reports show that PGE2 and an

analogue, produce ion fluxes

in the rat intestinal mucosa and both canine and frog gastric
mucosa.

Ruwart e t a l.

(1979) reported that PGE2 (1.0 mg/kg) de

creased calcium and phosphorus, but increased sodium and chloride
concentration in intestinal fluid.

Bolton e t a l.

(1978) showed

that the 16,16-dimethyl PGE2 induced non-parietal cell secretion,
from the canine gastric mucosa in v ivo .
high HC03-content.

This secretion contains a

Other reports support this finding.

Garner

e t a t. (1979) showed that 16,16-dimethyl PGE2 stimulated HC03secretion by the frog gastric mucosa.

If this is the case, then acid

neutralization by the bicarbonate could explain the decrease in acid
concentration produced by PGE2.
Hypertonic NaCI and mannitol administered into the duodenum
inhibited gastric secretion, increased hemoconcentration and stimu
lated intestinal secretion.

The mechanism of hypertonic fluid

induced inhibition of gastric secretion is not known.

Assouline

e t a l. (1978) found that hypertonic NaCI (2 ml of a 10% solution)
inhibited gastric acid output in the pylorus ligated rat.
in the stomach contents increased also.

PGE2

It was concluded thus,
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since prostaglandins possess antisecretory activity and hypertonic
NaCI stimulated prostaglandin production, then hypertonic solutions
inhibit gastric secretion through stimulating endogenous prosta
glandin production.

Adair (1976) found that 2 millimoles of NaCI

(given in a 2 ml volume) administered orally 2 hours before pylorus
ligation inhibited gastric secretion (acid concentration and output).
He concluded that hypertonic NaCI inhibited gastric secretion by
increasing gastric mucosal permeability to ions.

This cannot be

the case for intraduodenally administered hypertonic NaCI since
this route shows parental activity.

Adair did not show antisecre

tory effects of hypertonic NaCI after subcutaneous administration.
Therefore, intraduodenally administered hypertonic NaCI may inhibit
gastric secretion through mechanisms involving the gut with in
creased intestinal secretion playing a role.
The first demonstration of antisecretory activity afforded by
hypertonic solutions (glucose) was made by Leconte (1900) and later
by Clemm (1901).

Shay e t a l.

(1942) proposed a local osmoreceptor

mechanism to explain this gastric inhibitory action of hypertonic
solutions in the duodenum.

Sircus (1953) concluded that the mechanism

of osmotically induced inhibition of gastric secretion is hormonal in
nature after he demonstrated that hypertonic solutions inhibit gastric
secretion in dogs with innervated, denervated or transplanted fundie pouches.

Konturek and Grossman (1965) found that a 20% glucose

solution instilled into the duodenum inhibited the Heidenhain pouch
response to exogenous gastrin.
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From data presented here, it may be hypothesized that intestinal
secretion is the mechanism of action of osmotically induced inhibi
tion of gastric secretion.

Hypertonic solutions stimulate intestinal

secretion which in turn inhibits gastric secretion.

Thus, it is

likely that intestinal secretion (abnormal levels) may contribute
to the gastric volume inhibition by prostaglandins.
Increased intestinal secretion coincides with decreased gastric
secretion.

This is true when intestinal secretion is induced by

cholera toxin, hypertonic solutions or PGE2. Abundant intestinal
secretion may induce gut hormones or initiate osmoreceptor mechanisms
which may be involved in the regulation of gastric secretion.
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CONCLUSIONS

1.

Prostaglandin E2 does not inhibit gastric volume in the

gutless rat.

This property is unlike an anticholenergic antisecre

tory compound, methscopolamine bromide, which inhibits volume with
equal potency in both intact and gutless pylorus ligated rats.

Both

PGE2 and methscopolamine bromide inhibited acid concentration in the
gutless rat.

2.

PGE2 inhibits gastric volume and acid by separate mechanisms.

Gastric volume inhibition by PGE2 involves the gut perhaps through
substances produced by the gut.

3.

Expansion of extracellular fluid volume by intravenous iso

tonic fluids blocked PGE2 induced inhibition of gastric volume in
the pylorus ligated intact rat.

PGE2 plus intravenous fluid stim

ulated gastric volume in both intact and gutless pylorus ligated
rat.

4.

Hypertonic solutions (NaCI and mannitol) administered

intraduodenally, inhibited gastric secretion, stimulated intestinal
secretion and increased hemoconcentration.

The fluid loss through

intestinal secretion may be the reason for the lack of fluid in the
stomach.

5.

An abnormal increase in intestinal secretion, in itself,

may stimulate gut substances that regulate gastric secretion.
29
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